Key Details
Price
$20.79Annual Revenue
$6.97 BAnnual EPS
$0.47Annual ROE
6.35%Beta
0.80Events Calendar
Next earnings date:
Feb 14, 2025Recent quarterly earnings:
Oct 25, 2024Recent annual earnings:
Feb 14, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Screeners with AVTR included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Investors interested in Medical Services stocks may have come across Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). However, which of these companies is the better choice for those seeking undervalued stocks?
Sound Shore Management, an investment management company, has published its investor letter for the third quarter of 2024. You can download the letter here. In this quarter, the fund's Investor Class (SSHFX) and Institutional Class (SSHVX) saw increases of 6.70% and 6.74%, respectively, which is better than the 5.89% return of the Standard & Poor’s 500.
Avantor has a strong business model that provides steady cash flow and keeps customers loyal. Its leading position in the biopharma sector and changing revenue sources can lead to significant profit growth. The company’s ability to generate substantial free cash flow can enhance its financial stability and benefit shareholders.
Investors interested in Medical Services stocks may have come across Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). However, which of these two companies is the better choice for those seeking undervalued stocks?
Avantor, Inc. (NYSE: AVTR), a top global supplier of essential products and services for the life sciences and advanced technology sectors, has announced that its President and CEO, Michael Stubblefield, will take part in a fireside chat at the Evercore ISI HealthCONx Conference. This event will be held in Coral Gables, Florida, on Tuesday, December 3, at 9:10 a.m.
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI), known as The Protein Sequencing Company™, has revealed a distribution deal with Avantor® (NYSE: AVTR), a top provider of essential products and services for life sciences and advanced technology. This partnership will allow Avantor to distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) products, benefiting researchers in various fields.
Investors interested in the Medical Services sector may want to look at Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). However, which of these companies is the better choice for those seeking undervalued stocks?
Even though AVTR remains stable in the Education and Advanced Technology sectors, it has reported a weaker performance in the third quarter.
Avantor Inc. (NYSE:AVTR) will hold its Q3 2024 Earnings Conference Call on October 25, 2024, at 8:00 AM ET. The call will feature company representatives including Christina Jones, Michael Stubblefield, and Brent Jones, along with various participants from different financial institutions. The operator for the call is Emily, who will assist throughout the session.
The main figures for Avantor (AVTR) provide an overview of the company's performance for the quarter that ended in September 2024. However, it could be useful to compare these important metrics with Wall Street predictions and the results from the same period last year.
FAQ
- What is the primary business of Avantor?
- What is the ticker symbol for Avantor?
- Does Avantor pay dividends?
- What sector is Avantor in?
- What industry is Avantor in?
- What country is Avantor based in?
- When did Avantor go public?
- Is Avantor in the S&P 500?
- Is Avantor in the NASDAQ 100?
- Is Avantor in the Dow Jones?
- When was Avantor's last earnings report?
- When does Avantor report earnings?
- Should I buy Avantor stock now?